Skip to main content

Effects of Hydrochloric Acid and Formic Acid Decalcification on Breast Tumor Biomarkers and HER2 Fluorescence In Situ Hybridization.

Clark BZ, Yoest JM, Onisko A, Dabbs DJ

Publication: Appl Immunohistochem Mol Morphol (2019) • Vol 27 • Page 223-230PMID: 28877070View on PubMed

Purpose

This paper compared the effects of decalcification using hydrochloric acid (HCl) and formic acid (FA)-based solutions on immunohistochemical (IHC) staining and fluorescence in situ hybridization (FISH) analysis of breast cancer specimens.

Conclusion

No statistically significant differences in expression were identified between control specimens and those exposed to FA for either 1 h or 5 h for any of the markers. No statistically significant differences were observed for CK7, GCDFP-15, or mammaglobin expression patterns in any treatment group when compared with that of normal fixation. Staining results for 1 h FA were similar to 5 h FA and results for 5 h HCl were similar to 1 h HCl exposure. Staining intensities for ER, PR, Ki67, and GATA-3 were lower in tissues exposed to HCl for 1 h and 5 h when compared with control tissue (P<0.05) but only Ki67 staining was lower in specimens exposed to FA after 5 h (P=0.015). No Ki67 staining was observed in two cases after 1 h of HCl exposure and in four cases after 5 h HCl exposure. As expected, all cases were negative for CK20, Pax-8, and TTF-1. HER2 score was significantly lower following 1 h (P=0.017) and 5 h (P=0.011) of HCl exposure. HER2 FISH analysis showed 100% concordance in the eight archived specimens following both 1 and 5 h of FA exposure when compared with control specimens.

Studies (1)

Purpose

This study compared the effects of decalcification using hydrochloric acid (HCl) and formic acid (FA) solutions on IHC staining and FISH analysis of breast cancer specimens. Fifteen breast cancer tumors were divided into five pieces (~1.5 x 0.3 x 0.3 cm) and fixed in 10% neutral-buffered formalin overnight (~12 h). One piece remained in formalin as a control, two were placed into a HCl-based solution (one for 1 h and one for 5 h), and two placed into a FA-based solution (one for 1 and one for 5 h). Specimens subjected to decalcification were rinsed under running cold tap water for 30 sec and then placed along with the non-decalcified specimen in a single tissue cassette for automated processing. A single pathologist examined H&E slides and scored IHC slides stained for ER, PR, HER2, Ki67, cytokeratin 7 (CK7), cytokeratin 20 (CK20), GATA-3, gross cystic disease fluid protein-15 (GCDFP-15), mammaglobin, Pax-8, and TTF-1. Scoring for ER, PR, and GATA-3 was determined by multiplying the percentage of cells by their staining intensity (0=negative, 1+=weak, 2+=moderate, and 3+=strong) producing scores from 0 (completely negative) to 300 (100% of tumor cells strongly 3+ positive). HER2 was scored per the FDA-cleared Interpretation Guide for Ventana anti-HER2/neu (4B5) antibody. Ki67 was scored as a percentage of cells showing nuclear expression at any level of intensity. CK7, CK20, GCDFP-15, mammaglobin, Pax-8, and TTF-1 were scored based on intensity of immunoreactivity (0, 1+, 2+, or 3+). Archived tissue blocks from an additional eight breast tumors previously shown to be positive for HER2 by IHC (details not provided) were deparaffinized by warming in an embedding chamber and decalcified using the FA-based solution for 1 h or 5 h, washed, and reembedded in paraffin in separate blocks. Archived specimens were processed for IHC staining as described and FISH analysis using the Vysis HER-2 DNA Probe Kit was performed to determine concordance with previous IHC results.

Summary of Findings

IHC staining results for specimens decalcified in FA for 1 h were similar to those decalcified in FA for 5 h and results for specimens decalcified in HCl for 1 h were similar to those decalcified for 5 h. Staining intensities for ER, PR, Ki67, and GATA-3 were lower in tissues decalcified in HCl for 1 h and 5 h compared to matched non-decalcified tissue (P<0.05, all) but no statistically significant differences were identified for CK7, GCDFP-15, or mammaglobin. No Ki67 staining was observed in two cases after 1 h of HCl decalcification and in four cases after 5 h HCl decalcification. HER2 scores were significantly lower following 1 h (P=0.017) and 5 h (P=0.011) of HCl decalcification compared to matched non-decalcified controls. For specimens decalcified in FA solution, only Ki67 staining in specimens decalcified for 5 h were lower compared to matched non-decalcified specimens (P=0.015). As expected, all specimens were negative for CK20, Pax-8, and TTF-1. HER2 FISH analysis of eight archival specimens showed 100% concordance with previous IHC HER2 staining results following both 1 and 5 h of FA exposure.

  • Biospecimens

    TissueBreast
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    MorphologyH-and-E microscopy
    ProteinImmunohistochemistry
    DNAFISH
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Analyte Extraction and PurificationDecalcification solution/ duration
    formic acid solution for 1 h
    formic acid solution for 5 h
    hydrochloric acid solution for 1 h
    hydrochloric acid solution for 5 h
    no decalcification
    FISH SpecificTargeted nucleic acid
    HER2
    Immunohistochemistry SpecificTargeted peptide/protein
    ER
    GATA-3
    HER2
    Ki67
    PR
    Pax-8
    TTF-1
    cytokeratin 20 (CK20)
    cytokeratin 7 (CK7)
    gross cystic disease fluid protein-15 (GCDFP-15)
    mammaglobin